These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15378013)

  • 21. Thymosin beta-10 gene expression as a possible tool in diagnosis of thyroid neoplasias.
    Chiappetta G; Pentimalli F; Monaco M; Fedele M; Pasquinelli R; Pierantoni GM; Ribecco MT; Santelli G; Califano D; Pezzullo L; Fusco A
    Oncol Rep; 2004 Aug; 12(2):239-43. PubMed ID: 15254683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers.
    Mita Y; Yasuda Y; Sakai A; Yamamoto H; Toyooka S; Gunduz M; Tanabe S; Naomoto Y; Ouchida M; Shimizu K
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):249-59. PubMed ID: 19672627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis.
    van Staveren WC; Solís DW; Delys L; Venet D; Cappello M; Andry G; Dumont JE; Libert F; Detours V; Maenhaut C
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):413-8. PubMed ID: 16381821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis.
    Trapasso F; Drusco A; Costinean S; Alder H; Aqeilan RI; Iuliano R; Gaudio E; Raso C; Zanesi N; Croce CM; Fusco A
    DNA Cell Biol; 2006 Jun; 25(6):376-82. PubMed ID: 16792508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTPRJ haplotypes and colorectal cancer risk.
    Toland AE; Rozek LS; Presswala S; Rennert G; Gruber SB
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2782-5. PubMed ID: 18843023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comments on: "Meta-analysis of association between Arg326Gln (rs1503185) and Gln276Pro (rs1566734) polymorphisms of PTPRJ gene and cancer risk".
    Gholami M; M Amoli M
    J Appl Genet; 2019 Nov; 60(3-4):431-433. PubMed ID: 31301025
    [No Abstract]   [Full Text] [Related]  

  • 29. The eighth fibronectin type III domain of protein tyrosine phosphatase receptor J influences the formation of protein complexes and cell localization.
    Iuliano R; Raso C; Quintiero A; Pera IL; Pichiorri F; Palumbo T; Palmieri D; Pattarozzi A; Florio T; Viglietto G; Trapasso F; Croce CM; Fusco A
    J Biochem; 2009 Mar; 145(3):377-85. PubMed ID: 19122201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.
    Máximo V; Lima J; Soares P; Botelho T; Gomes L; Sobrinho-Simões M
    Mitochondrion; 2005 Oct; 5(5):333-40. PubMed ID: 16183030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein e expression in anaplastic thyroid carcinoma.
    Ito Y; Takano T; Miyauchi A
    Oncology; 2006; 71(5-6):388-93. PubMed ID: 17690558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of heterozygosity in 73 human thyroid tumors.
    Wozniak A; Wiench M; Olejniczak A; Wloch J; Lachinski A; Lange D; Olczyk T; Jarzab B; Limon J
    Neuro Endocrinol Lett; 2005 Oct; 26(5):521-5. PubMed ID: 16264407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).
    Aya-Bonilla C; Camilleri E; Haupt LM; Lea R; Gandhi MK; Griffiths LR
    BMC Genomics; 2014 May; 15(1):390. PubMed ID: 24885312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic dysregulation in thyroid neoplasia.
    Kondo T; Asa SL; Ezzat S
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):389-400, ix. PubMed ID: 18502333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer.
    Rogounovitch TI; Saenko VA; Ashizawa K; Sedliarou IA; Namba H; Abrosimov AY; Lushnikov EF; Roumiantsev PO; Konova MV; Petoukhova NS; Tchebotareva IV; Ivanov VK; Chekin SY; Bogdanova TI; Tronko MD; Tsyb AF; Thomas GA; Yamashita S
    Oncol Rep; 2006 Apr; 15(4):949-56. PubMed ID: 16525684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer.
    Luo L; Shen GQ; Stiffler KA; Wang QK; Pretlow TG; Pretlow TP
    Carcinogenesis; 2006 Jun; 27(6):1153-9. PubMed ID: 16474178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD117 expression in normal, neoplastic, inflammatory, and reactive lesions of the thyroid.
    Aydin O; Yildiz L; Kefeli M; Kandemir B
    Pathol Res Pract; 2008; 204(6):359-65. PubMed ID: 18337018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas.
    Ishiguro K; Yoshida T; Yagishita H; Numata Y; Okayasu T
    Gut; 2006 May; 55(5):695-702. PubMed ID: 16354798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells.
    Mitsutake N; Knauf JA; Mitsutake S; Mesa C; Zhang L; Fagin JA
    Cancer Res; 2005 Mar; 65(6):2465-73. PubMed ID: 15781663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid cancer susceptibility and THRA1 and BAT-40 repeats polymorphisms.
    Baida A; Farrington SM; Galofré P; Marcos R; Velázquez A
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):638-42. PubMed ID: 15767343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.